Loading…
Pliant Therapeutics, Inc. is projected to rise to $1.04 by 2027, a 0% move from its current price of $1.04. PLRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.02 | $1.04 | $1.06 | -0.01% |
| Aug 6 | $1.01 | $1.04 | $1.07 | -0.02% |
| Aug 7 | $1.00 | $1.04 | $1.08 | -0.03% |
| Aug 8 | $0.9992 | $1.04 | $1.08 | -0.05% |
| Aug 9 | $0.9945 | $1.04 | $1.09 | -0.06% |
| Aug 10 | $0.9902 | $1.04 | $1.09 | -0.07% |
| Aug 11 | $0.9862 | $1.04 | $1.09 | -0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.9862 | $1.04 | $1.09 | -0.08% |
| Week 2 | $0.9643 | $1.04 | $1.12 | -0.16% |
| Week 3 | $0.9476 | $1.04 | $1.14 | -0.24% |
| Week 4 | $0.9337 | $1.04 | $1.15 | -0.32% |
| Week 5 | $0.9215 | $1.04 | $1.16 | -0.40% |
| Week 6 | $0.9105 | $1.03 | $1.18 | -0.48% |
| Week 7 | $0.9005 | $1.03 | $1.19 | -0.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing integrin-based therapeutics for solid tumors.
Its lead candidate PLN-101095 is an oral, small molecule dual inhibitor of avß8 and avß1 integrins and is in Phase 1a/1b for the treatment of solid tumors.
The company was incorporated in 2015 and is headquartered in South San Francisco, California.
PLRX is currently trading at $1.07 with a market capitalization of $66.25M. It ranks 4162 by market cap among publicly traded assets.
The 30-day technical picture shows bearish sentiment, with RSI(14) at 40, the 50-day simple moving average at $1.17 and the 200-day simple moving average at $1.32. Near-term support is at $1.07 and resistance at $1.19, with a 30-day price range of $0.9125 to $1.25.
The asset exhibits annualized volatility of 50%. The multi-year forecast implies a path of rising prices, starting from a 2026 average of $1.07 and reaching higher horizons, with 2050 expected average price of $3.94 and a maximum forecast of $6.96.
A major floor 8.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 12.5% above — a clean break opens room to run.
A major ceiling 30.8% above — clearing it would confirm fresh momentum.
Key PLRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.06 | Sell | $1.06 | Sell |
| MA 10 | $1.07 | Sell | $1.07 | Sell |
| MA 20 | $1.10 | Sell | $1.09 | Sell |
| MA 50 | $1.15 | Sell | $1.14 | Sell |
| MA 100 | $1.21 | Sell | $1.19 | Sell |
| MA 200 | $1.30 | Sell | $1.56 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.76 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -135.50 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -7.14 | Sell |
| Bollinger %B (20,2) | 0.06 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.27 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 27.23 | Buy |
| Momentum (10) | -0.11 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 1.04 | Sell |
| ADX (14) | 14.56 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day picture indicates near-term bearish momentum.
RSI(14) is 40; the 50-day SMA is $1.17 and the 200-day SMA is $1.32.
Support is at $1.07 and resistance at $1.19, with the 30-day price range ranging from $0.9125 to $1.25.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.04 | $1.04 | $1.23 | 0% | Neutral | |
| $0.8514 | $1.04 | $1.33 | 0% | Neutral | |
| $0.8591 | $1.07 | $1.41 | +3% | Neutral | |
| $0.8838 | $1.12 | $1.51 | +8% | Neutral | |
| $0.9136 | $1.18 | $1.61 | +13% | Neutral | |
| $1.05 | $1.37 | $1.91 | +32% | Bullish | |
| $1.18 | $1.56 | $2.20 | +50% | Bullish | |
| $1.17 | $1.56 | $2.23 | +50% | Bullish | |
| $1.19 | $1.61 | $2.34 | +55% | Bullish | |
| $1.20 | $1.63 | $2.40 | +57% | Bullish | |
| $1.74 | $2.48 | $3.82 | +138% | Bullish | |
| $2.62 | $4.02 | $6.67 | +287% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.04 | $1.04 | $1.24 | +0.00% |
| September 2026 | $0.8712 | $1.02 | $1.23 | -1.71% |
| October 2026 | $0.8729 | $1.03 | $1.25 | +0.68% |
| November 2026 | $0.8733 | $1.03 | $1.26 | +0.45% |
| December 2026 | $0.8445 | $1.00 | $1.23 | -2.94% |
Click any year to see its month-by-month PLRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PLRX could reach as high as $1.23, with a base case around $1.04 and support toward $1.04 — roughly 0% from $1.04. A consolidation phase looks the most probable path here.
Expect PLRX to range from $0.8514 to $1.33 through 2027. The $1.04 average target implies a 0% move from current prices. That is up 0% on the projected 2026 average. Price action looks broadly range-bound.
The PLRX price prediction for 2028 points to an average of $1.07 (low $0.8591, high $1.41) — a potential gain of +3% on today's $1.04. A consolidation phase looks the most probable path here.
In 2029, PLRX is projected to trade between $0.8838 and $1.51, averaging $1.12 — a potential gain of +8% from today's $1.04. That is up +5% on the projected 2028 average. Price action looks broadly range-bound.
Pliant Therapeutics, Inc.'s 2030 outlook centres on $1.18, within a $0.9136 to $1.61 range. That is up +5% on the projected 2029 average. That marks a +13% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, PLRX could reach as high as $1.91, with a base case around $1.37 and support toward $1.05 — roughly +32% from $1.04. Momentum favours further upside here.
Expect PLRX to range from $1.18 to $2.20 through 2032. The $1.56 average target implies a +50% move from current prices. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The PLRX price prediction for 2033 points to an average of $1.56 (low $1.17, high $2.23) — a potential gain of +50% on today's $1.04. Momentum favours further upside here.
In 2034, PLRX is projected to trade between $1.19 and $2.34, averaging $1.61 — a potential gain of +55% from today's $1.04. That is up +3% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Pliant Therapeutics, Inc.'s 2035 outlook centres on $1.63, within a $1.20 to $2.40 range. That is up +1% on the projected 2034 average. That marks a +57% change versus current levels. Momentum favours further upside here.
By 2040, PLRX could reach as high as $3.82, with a base case around $2.48 and support toward $1.74 — roughly +138% from $1.04. Buyers look set to stay in control over this stretch.
Expect PLRX to range from $2.62 to $6.67 through 2050. The $4.02 average target implies a +287% move from current prices. That is up +62% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in PLRX today (≈ 961.538462 PLRX) could be worth
$3,869.75
+$2,869.75 (+287%) by 2050 · US Dollar
Based on the average projected PLRX price of $4.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLRXwould be worth at today's price.
$1,000 invested in PLRX on Jul 31, 2025 (≈ 684.931489 PLRX) would be worth
$712.33
-$287.67 (-28.8%) today · 0.71× · US Dollar
Based on a PLRX entry price of $1.46 vs. today's $1.04.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.09 | $954.13 | -4.6% |
| 1 month ago | $1.11 | $936.94 | -6.3% |
| 3 months ago | $1.2 | $866.67 | -13.3% |
| 6 months ago | $1.19 | $873.95 | -12.6% |
| 1 year ago | $1.46 | $712.33 | -28.8% |
| All time (5.0y) ago | $22.39 | $46.45 | -95.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLRX forecast.
Our base-case forecast reaches $2.10 around 2040.
Implied market cap at $2.10: $130.03M
The multi-year forecast shows a gradual upside from 2026 onward. The 2026 average is $1.07 with a 0% ROI and Neutral sentiment.
By 2030, the average is $1.19 with an 11.7% ROI and Neutral sentiment.
From 2031 onward the outlook turns Bullish, with 2031 average $1.39 and 29.6% ROI; 2032 average $1.57 and 46.6% ROI; 2033 average $1.59 and 48.1% ROI; 2034 average $1.60 and 49.4% ROI; 2035 average $1.62 and 51.5% ROI.
The forecast accelerates into the 2040s and 2050s, with 2040 average $2.48 and 131.8% ROI; 2050 average $3.94 and 267.9% ROI, and a max forecast of $6.96. These are estimates, not guarantees, and depend on market conditions and development outcomes.
Tap a question to reveal the answer.
Avg $1.19, min $0.9038, max $1.70; ROI 11.7%; sentiment Neutral.
Forecasts show Neutral to Bullish sentiment over time, with ROIs of 29.6% in 2031, 46.6% in 2032, 48.1% in 2033, 49.4% in 2034, 51.5% in 2035, 131.8% by 2040, and 267.9% by 2050.
Yes. The forecast shows 2031 max $2.01, 2032 max $2.31, 2033 max $2.37, 2034 max $2.43, and 2035 max $2.49.
Bearish sentiment with RSI(14) at 40. The 50-day SMA is $1.17 and the 200-day SMA is $1.32. Support is at $1.07 and resistance at $1.19. The 30-day price range is $0.9125 to $1.25, and annualized volatility is 50%.
Max $6.96, avg $3.94, min $2.38; ROI 267.9%; sentiment Bullish.
Pliant Therapeutics, Inc. Community Discussion
0Share your Pliant Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.